The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Abbvie; Bristol-Myers Squibb/Pfizer; Johnson & Johnson/Janssen; Merck
Impact of age and gender on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC): Subgroup analysis of the PANAMA-study (AIO-KRK-0212).
 
Kathrin Heinrich
Consulting or Advisory Role - SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; Lilly
 
Meinolf Karthaus
Consulting or Advisory Role - Amgen
Travel, Accommodations, Expenses - Amgen
 
Stefan Fruehauf
No Relationships to Disclose
 
Ullrich Graeven
Stock and Other Ownership Interests - Biontech
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Fujifilm; MSD Oncology; Novartis; Sanofi Aventis GmbH
Consulting or Advisory Role - Amgen; MSD Oncology
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim; GlaxoSmithKline; Merck KGaA
 
Lothar Müller
No Relationships to Disclose
 
Alexander Koenig
Honoraria - IPSEN; Pierre Fabre
Consulting or Advisory Role - Roche Pharma AG
 
Ludwig von Weikersthal
Honoraria - AstraZeneca; Lilly; Novartis; Pierre Fabre; Roche Pharma AG
 
Karel Caca
No Relationships to Disclose
 
Albrecht Kretzschmar
Honoraria - Amgen; Aspen Pharma; Bayer Schering Pharma; Bristol-Myers Squibb; Medac; Merck Serono; MSD; Roche Pharma AG; Sanofi; SERVIER; Shire
Consulting or Advisory Role - Amgen; Roche Pharma AG; Shire
Travel, Accommodations, Expenses - Ipsen; Medac; Merck Serono; PharmaMar
 
Eray Goekkurt
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Roche; Sanofi
 
Siegfried Haas
Travel, Accommodations, Expenses - Ipsen
 
Annabel Helga Sophie Alig
Consulting or Advisory Role - MSD
 
Annika Kurreck
Honoraria - SERVIER
Travel, Accommodations, Expenses - Medac; Roche
 
Arndt Stahler
Honoraria - Roche; SERVIER; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Amgen; Lilly; Pfizer; Roche
 
Swantje Held
No Relationships to Disclose
 
Anke C. Reinacher-Schick
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; MCI Group; Merck Serono; MSD; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD; Pierre Fabre; Roche
Research Funding - AIO-Studien (Inst); Alexion Pharmaceuticals (Inst); Amgen (Inst); AstraZeneca (Inst); BioNTech (Inst); Celgene (Inst); ERYTECH Pharma (Inst); Ipsen (Inst); Lilly (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Roche
 
Volker Heinemann
Honoraria - Amgen; AstraZeneca; Merck; Pfizer; Pierre Fabre; Roche; Sanofi; SERVIER; Sirtex Medical
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Merck; MSD; MSD Oncology; Novartis; Pierre Fabre; Roche; Sanofi; Sirtex Medical; TERUMO
Research Funding - Amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Merck (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Servier (Inst); Sirtex Medical (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Merck; Roche; SERVIER; Sirtex Medical
 
Sebastian Stintzing
Honoraria - Amgen; Bayer; LEO Pharma; Lilly; Merck KGaA; MSD; Pierre Fabre; Roche; Sanofi; SERVIER; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Lilly; Merck KGaA; MSD; Pierre Fabre; Roche; Sanofi; Sanofi; SERVIER; Takeda
Research Funding - Merck Serono (Inst); Pierre Fabre (Inst); Roche Molecular Diagnostics (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Lilly; Merck KGaA; Pierre Fabre; Roche; Sanofi; Sirtex Medical; Takeda
 
Tanja Trarbach
Research Funding - Amgen (Inst)
Travel, Accommodations, Expenses - Abbvie (Inst); Amgen (Inst); Ipsen (Inst); Johnson & Johnson/Janssen (Inst); MSD (Inst); Novartis (Inst); OMT (Inst); Sanofi/Aventis (Inst); Takeda (Inst)
 
Dominik Paul Modest
Honoraria - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Incyte; Lilly; Merck Serono; Merck Sharp & Dohme; Onkowissen; Pierre Fabre; Sanofi; SERVIER; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Cor2Ed; Incyte; IQvia; Lilly; Merck Serono; Merck Sharp & Dohme; Onkowissen; Pierre Fabre; Roche; SERVIER
Research Funding - Amgen (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Amgen; Merck Serono; SERVIER